• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GXE:GR

15.710 EUR 0.330 2.06%

As of 02:52:41 ET on 04/16/2014.

Snapshot for Galapagos NV (GXE)

Open: 15.460 Day's Range: 15.460 - 15.710 Volume: 300
Previous Close: 16.040 52wk Range: 13.400 - 20.145 1-Yr Rtn: -16.17%

Stock Chart for GXE

No chart data available.
  • GXE:GR 15.710
  • 1D
  • 1M
  • 1Y
16.040
Interactive GXE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GXE

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) -0.7630
Est. PEG Ratio -
Market Cap (M EUR) 472.85
Shares Outstanding (M) 30.10
30 Day Average Volume 603
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GXE

No data available

Company Profile & Key Executives for GXE

Galapagos NV is a drug discovery company focused on the identification of disease modifying drug targets. The Company specializes in osteoporosis, rheumatoid arthritis, osteoarthritis and Alzheimer's disease.

Onno Van De StolpeCEO/Executive DirectorGuillaume JettenChief Financial Officer
Piet WigerinckChief Scientific OfficerDavid SmithCEO:Service Division
More Company Profile & Key Executives for GXE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil